Popular
The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
CME/CEThe Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke: Primary Results of the VESALIUS-CV Trial
CardiologyEvolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke: Primary Results of the VESALIUS-CV Trial
Relapsed or Refractory DLBCL: Reviewing the Expanding Treatment Landscape
Project Oncology®Relapsed or Refractory DLBCL: Reviewing the Expanding Treatment Landscape
Updates in Major Depressive Disorder with Insomnia
CME/CEUpdates in Major Depressive Disorder with Insomnia
Individualizing gMG Treatment: Defining Success With Each Patient
NeuroFrontiersIndividualizing gMG Treatment: Defining Success With Each Patient
Programs
Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke: Primary Results of the VESALIUS-CV Trial
CardiologyEvolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke: Primary Results of the VESALIUS-CV Trial
Primary Results of the VESALIUS-CV Trial: Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke
CardiologyPrimary Results of the VESALIUS-CV Trial: Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke
Advancing Care for Women With Aortic Stenosis: 2-Year Outcomes for Women in the 5-Year SMART Trial
CardiologyAdvancing Care for Women With Aortic Stenosis: 2-Year Outcomes for Women in the 5-Year SMART Trial
Improving Home BP Monitoring: Inside the AMA’s Validated Device Listing
Perspectives with the AMAImproving Home BP Monitoring: Inside the AMA’s Validated Device Listing
Sotagliflozin in HFpEF Without Diabetes: Inside the SOTA-P-CARDIA Trial from AHA 2025
CardiologySotagliflozin in HFpEF Without Diabetes: Inside the SOTA-P-CARDIA Trial from AHA 2025
Clinical Practice
Relapsed or Refractory DLBCL: Reviewing the Expanding Treatment Landscape
Project Oncology®Relapsed or Refractory DLBCL: Reviewing the Expanding Treatment Landscape
Optimizing Generalized Myasthenia Gravis Care Through Patient-Centered Choices
NeuroFrontiersOptimizing Generalized Myasthenia Gravis Care Through Patient-Centered Choices
Next-Gen Clinical Monitoring: Predicting Inpatient Decline with AI-Driven Alerts
The ConvergenceNext-Gen Clinical Monitoring: Predicting Inpatient Decline with AI-Driven Alerts
Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Project Oncology®Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Implications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
NephrologyImplications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
Doctors Lounge
"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
The Convergence"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
On the Frontlines of Multiple SclerosisUncovering Disparities in Teleneurology Utilization Post-Pandemic
Messy Labs, Major Breakthroughs: The Happy Accidents That Shaped Modern Medicine
Rub Some Dirt In ItMessy Labs, Major Breakthroughs: The Happy Accidents That Shaped Modern Medicine
Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
Clinician's RoundtableArtificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Project Oncology®Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
On the Frontlines of Multiple SclerosisMS Management: Strategies for Ensuring Equitable Access to Teleneurology
CME
Updates in Major Depressive Disorder with Insomnia
CME/CEUpdates in Major Depressive Disorder with Insomnia
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need
CME/CETreating MASH With Compensated Cirrhosis: A Serious Unmet Need
Advancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment
CME/CEAdvancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
CME/CEOptimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Navigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®
CME/CENavigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
CME/CEMuscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
Industry Feature
MMN in Practice: A Rare Motor Neuropathy Often Misdiagnosed
Medical Industry FeatureMMN in Practice: A Rare Motor Neuropathy Often Misdiagnosed
Understanding Dual Inhibition of IL-17
Medical Industry FeatureUnderstanding Dual Inhibition of IL-17
Evidence Builds for Cell-Based Influenza Vaccines
Medical Industry FeatureEvidence Builds for Cell-Based Influenza Vaccines
The Importance of Diagnosing Dry Eye Disease Early
Medical Industry FeatureThe Importance of Diagnosing Dry Eye Disease Early
What Is Macrophage Activation Syndrome?
Medical Industry FeatureWhat Is Macrophage Activation Syndrome?
Inhibiting Inflammation in Dry Eye Disease
Medical Industry FeatureInhibiting Inflammation in Dry Eye Disease